Nav: Home

Public views of gene editing for babies depend on how it would be used

July 26, 2018

WASHINGTON, D.C. (July 26, 2018) - A majority of Americans support the idea of using gene editing with the goal of delivering direct health benefits for babies. At the same time, a majority also considers the use of gene editing to boost a baby's intelligence as something that takes technology "too far," according to a new study released today by Pew Research Center.

Some 72% of Americans say that changing an unborn baby's genetic characteristics to treat a serious disease or condition that the baby would have at birth is an appropriate use of medical technology, according to the nationally representative survey of 2,537 U.S. adults conducted April 23-May 6, 2018.

A smaller share of Americans say gene editing to reduce a baby's risk of developing a serious disease or condition over their lifetime is appropriate (60% say this would be appropriate, and 38% say it would be taking medical technology too far). But, when the survey asked about using the same technology to make a baby more intelligent, just 19% of Americans say it would be appropriate.

When considering the possibility that development of gene editing would entail testing on human embryos, only one third of Americans (33%) say this would be appropriate while about two thirds (65%) say this would be taking medical technology too far.

There are large differences in acceptance of gene editing between the highly religious and less religious. Americans with high levels of religious commitment are closely divided over whether it is appropriate to use gene editing to reduce a baby's risk of disease later in life; 46% say this is appropriate while 53% consider it taking technology too far. In contrast, 73% of those low in religious commitment say gene editing to reduce a baby's risk of developing a serious disease or condition over their lifetime is an appropriate use of medical technology.

As people think about a future with possible widespread use of gene editing to change a baby's genetic make-up, the survey finds more anticipate negative than positive effects on society. Specifically, 58% believe gene editing will very likely lead to increased inequality because it will only be available to the wealthy. Some 54% of Americans anticipate a slippery slope, saying it's very likely that "even if gene editing is used appropriately in some cases, others will use these techniques in ways that are morally unacceptable." In contrast, only 18% of U.S. adults consider it very likely that development of gene editing techniques will pave the way for new medical advances that benefit society as a whole.

Among other findings:

Men are more accepting than women of using gene editing to change a baby's genetic makeup:
  • 65% of men believe that gene editing to reduce a baby's risk of developing a serious disease later in life is an appropriate use of medical technology, compared with 54% of women.
  • Men (76%) are more supportive than women (68%) of using gene editing to treat a congenital disorder.
  • More men (43%) than women (24%) consider embryonic testing to develop gene editing technology appropriate.
Americans with high levels of science knowledge are more likely to view gene editing positively:
  • 86% of those with high science knowledge, based on a nine-item index, believe it is appropriate to use gene editing to treat a congenital disorder, compared with 58% of those with low science knowledge and 72% with medium science knowledge.
  • 71% of those with high science knowledge say it is appropriate to use gene editing to reduce a baby's risk of disease that would occur later in life, compared with 49% of those with low science knowledge.
To read the report on July 26, click here:

For more information or to arrange an interview, please contact Haley Nolan by phone at 202-419-4372 or by email at Research Center is a nonpartisan fact tank that informs the public about the issues, attitudes and trends shaping America and the world. It does not take policy positions. The center is a subsidiary of The Pew Charitable Trusts, its primary funder.

Pew Research Center

Related Technology Articles:

April's SLAS Technology is now available
April's Edition of SLAS Technology Features Cover Article, 'CURATE.AI: Optimizing Personalized Medicine with Artificial Intelligence'.
Technology in higher education: learning with it instead of from it
Technology has shifted the way that professors teach students in higher education.
Post-lithium technology
Next-generation batteries will probably see the replacement of lithium ions by more abundant and environmentally benign alkali metal or multivalent ions.
Rethinking the role of technology in the classroom
Introducing tablets and laptops to the classroom has certain educational virtues, according to Annahita Ball, an assistant professor in the University at Buffalo School of Social Work, but her research suggests that tech has its limitations as well.
The science and technology of FAST
The Five hundred-meter Aperture Spherical radio Telescope (FAST), located in a radio quiet zone, with the targets (e.g., radio pulsars and neutron stars, galactic and extragalactic 21-cm HI emission).
AI technology could help protect water supplies
Progress on new artificial intelligence (AI) technology could make monitoring at water treatment plants cheaper and easier and help safeguard public health.
Transformative technology
UC Davis neuroscientists have developed fluorescence sensors that are opening a new era for the optical recording of dopamine activity in the living brain.
Do the elderly want technology to help them take their medication?
Over 65s say they would find technology to help them take their medications helpful, but need the technology to be familiar, accessible and easy to use, according to research by Queen Mary University of London and University of Cambridge.
Technology detecting RNase activity
A KAIST research team of Professor Hyun Gyu Park at Department of Chemical and Biomolecular Engineering developed a new technology to detect the activity of RNase H, a RNA degrading enzyme.
Taking technology to the next level
Physicists from the ARC Centre of Excellence for Ultrahigh bandwidth Devices for Optical Systems (CUDOS) developed a new hybrid integrated platform, promising to be a more advanced alternative to conventional integrated circuits.
More Technology News and Technology Current Events

Trending Science News

Current Coronavirus (COVID-19) News

Top Science Podcasts

We have hand picked the top science podcasts of 2020.
Now Playing: TED Radio Hour

Listen Again: Reinvention
Change is hard, but it's also an opportunity to discover and reimagine what you thought you knew. From our economy, to music, to even ourselves–this hour TED speakers explore the power of reinvention. Guests include OK Go lead singer Damian Kulash Jr., former college gymnastics coach Valorie Kondos Field, Stockton Mayor Michael Tubbs, and entrepreneur Nick Hanauer.
Now Playing: Science for the People

#562 Superbug to Bedside
By now we're all good and scared about antibiotic resistance, one of the many things coming to get us all. But there's good news, sort of. News antibiotics are coming out! How do they get tested? What does that kind of a trial look like and how does it happen? Host Bethany Brookeshire talks with Matt McCarthy, author of "Superbugs: The Race to Stop an Epidemic", about the ins and outs of testing a new antibiotic in the hospital.
Now Playing: Radiolab

Dispatch 6: Strange Times
Covid has disrupted the most basic routines of our days and nights. But in the middle of a conversation about how to fight the virus, we find a place impervious to the stalled plans and frenetic demands of the outside world. It's a very different kind of front line, where urgent work means moving slow, and time is marked out in tiny pre-planned steps. Then, on a walk through the woods, we consider how the tempo of our lives affects our minds and discover how the beats of biology shape our bodies. This episode was produced with help from Molly Webster and Tracie Hunte. Support Radiolab today at